Latest Octagon Capital Advisors LP Stock Portfolio
$624Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Octagon Capital Advisors LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Octagon Capital Advisors LP reported an equity portfolio of $650.9 Millions as of 30 Sep, 2023.
The top stock holdings of Octagon Capital Advisors LP are APLS, ROIV, CBAY. The fund has invested 18.3% of it's portfolio in APELLIS PHARMACEUTICALS INC and 7.8% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off DISC MEDICINE INC, TANDEM DIABETES CARE INC (TNDM) and GERON CORP (GERN) stocks. They significantly reduced their stock positions in ITEOS THERAPEUTICS INC (ITOS), HEPION PHARMACEUTICALS INC (HEPA) and VIR BIOTECHNOLOGY INC (VIR). Octagon Capital Advisors LP opened new stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), TAYSHA GENE THERAPIES INC (TSHA) and DIANTHUS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to MONTE ROSA THERAPEUTICS INC (GLUE), INOZYME PHARMA INC (INZY) and INSMED INC (INSM).
The top stock holdings of Octagon Capital Advisors LP are APLS, ROIV, CBAY. The fund has invested 18.3% of it's portfolio in APELLIS PHARMACEUTICALS INC and 7.8% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off DISC MEDICINE INC, TANDEM DIABETES CARE INC (TNDM) and GERON CORP (GERN) stocks. They significantly reduced their stock positions in ITEOS THERAPEUTICS INC (ITOS), HEPION PHARMACEUTICALS INC (HEPA) and VIR BIOTECHNOLOGY INC (VIR). Octagon Capital Advisors LP opened new stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), TAYSHA GENE THERAPIES INC (TSHA) and DIANTHUS THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to MONTE ROSA THERAPEUTICS INC (GLUE), INOZYME PHARMA INC (INZY) and INSMED INC (INSM).
New Buys
| Ticker | $ Bought |
|---|---|
| STRUCTURE THERAPEUTICS INC | 16,874,600 |
| IMMUNOVANT INC | 11,513,700 |
| CYTOKINETICS INC | 9,684,840 |
| RAPT THERAPEUTICS INC | 7,256,200 |
| GRACELL BIOTECHNOLOGIES INC | 5,989,970 |
| VERU INC | 2,736,000 |
| ANAPTYSBIO INC | 2,570,400 |
| NUVATION BIO INC | 1,510,000 |
New stocks bought by Octagon Capital Advisors LP
Additions
| Ticker | % Inc. |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | 333 |
| ALPINE IMMUNE SCIENCES INC | 65.51 |
| DIANTHUS THERAPEUTICS INC | 15.42 |
| DYNE THERAPEUTICS INC | 14.43 |
| GOSSAMER BIO INC | 12.21 |
Additions to existing portfolio by Octagon Capital Advisors LP
Reductions
| Ticker | % Reduced |
|---|---|
| INOZYME PHARMA INC | -69.23 |
| ROIVANT SCIENCES LTD | -42.89 |
| VIRIDIAN THERAPEUTICS INC | -41.9 |
| BRIDGEBIO PHARMA INC | -27.26 |
| AN2 THERAPEUTICS INC | -23.4 |
| XILIO THERAPEUTICS INC | -23.01 |
| AEROVATE THERAPEUTICS INC | -18.84 |
| CYMABAY THERAPEUTICS INC | -13.01 |
Octagon Capital Advisors LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| TAYSHA GENE THERAPIES INC | -8,777,780 |
| LEXICON PHARMACEUTICALS INC | -2,096,150 |
| 89BIO INC | -18,823,800 |
| PMV PHARMACEUTICALS INC | -5,550,560 |
| MONTE ROSA THERAPEUTICS INC | -3,893,770 |
| AMYLYX PHARMACEUTICALS INC | -12,725,400 |
| MIRATI THERAPEUTICS INC | -28,534,000 |
| VIKING THERAPEUTICS INC | -4,151,250 |
Octagon Capital Advisors LP got rid off the above stocks
Current Stock Holdings of Octagon Capital Advisors LP
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACRS | ACLARIS THERAPEUTICS INC | 0.02 | 100,000 | 105,000 | NEW | ||
| ALPN | ALPINE IMMUNE SCIENCES INC | 3.79 | 1,241,300 | 23,659,200 | ADDED | 65.51 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ANAB | ANAPTYSBIO INC | 0.41 | 120,000 | 2,570,400 | NEW | ||
| ANNX | ANNEXON INC | 1.49 | 2,050,000 | 9,307,000 | UNCHANGED | 0.00 | |
| ANTX | AN2 THERAPEUTICS INC | 2.18 | 664,575 | 13,617,100 | REDUCED | -23.4 | |
| APLS | APELLIS PHARMACEUTICALS INC | 26.89 | 2,806,980 | 168,026,000 | REDUCED | -10.32 | |
| AVTE | AEROVATE THERAPEUTICS INC | 1.46 | 403,685 | 9,135,390 | REDUCED | -18.84 | |
| BBIO | BRIDGEBIO PHARMA INC | 4.57 | 706,800 | 28,533,500 | REDUCED | -27.26 | |
| BNOX | BIONOMICS LIMITED | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CBAY | CYMABAY THERAPEUTICS INC | 10.11 | 2,673,750 | 63,154,000 | REDUCED | -13.01 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 4.49 | 707,526 | 28,060,500 | REDUCED | -6.89 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 2.62 | 2,060,100 | 16,398,400 | ADDED | 333 | |
| CYTK | CYTOKINETICS INC | 1.55 | 116,000 | 9,684,840 | NEW | ||
| DYN | DYNE THERAPEUTICS INC | 1.69 | 792,945 | 10,546,200 | ADDED | 14.43 | |
| ETNB | 89BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| GLYC | GLYCOMIMETICS INC | 1.13 | 3,000,000 | 7,080,000 | UNCHANGED | 0.00 | |
| GOSS | GOSSAMER BIO INC | 1.34 | 9,187,880 | 8,383,940 | ADDED | 12.21 | |
| GRCL | GRACELL BIOTECHNOLOGIES INC | 0.96 | 596,611 | 5,989,970 | NEW | ||
| HEPA | HEPION PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMVT | IMMUNOVANT INC | 1.84 | 273,289 | 11,513,700 | NEW | ||
| INSM | INSMED INC | 6.37 | 1,284,000 | 39,791,200 | UNCHANGED | 0.00 | |
| INZY | INOZYME PHARMA INC | 0.27 | 400,000 | 1,704,000 | REDUCED | -69.23 | |
| ITOS | ITEOS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| JSPR | JASPER THERAPEUTICS INC | 0.56 | 4,468,110 | 3,525,340 | UNCHANGED | 0.00 | |
| LXRX | LEXICON PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.12 | 25,000 | 738,000 | NEW | ||
| MRTX | MIRATI THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NUVB | NUVATION BIO INC | 0.24 | 1,000,000 | 1,510,000 | NEW | ||
| ORIC | ORIC PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PHAT | PHATHOM PHARMACEUTICALS INC | 0.07 | 50,000 | 456,500 | NEW | ||
| PMVP | PMV PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| RAPT | RAPT THERAPEUTICS INC | 1.16 | 292,000 | 7,256,200 | NEW | ||
| RCUS | ARCUS BIOSCIENCES INC | 5.71 | 1,868,000 | 35,678,800 | REDUCED | -5.08 | |
| ROIV | ROIVANT SCIENCES LTD | 4.48 | 2,494,000 | 28,007,600 | REDUCED | -42.89 | |
| RPHM | RENEO PHARMACEUTICALS INC | 0.58 | 2,250,000 | 3,600,000 | REDUCED | -1.31 | |
| TSHA | TAYSHA GENE THERAPIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VERU | VERU INC | 0.44 | 3,800,000 | 2,736,000 | NEW | ||
| VIR | VIR BIOTECHNOLOGY INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VKTX | VIKING THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2.16 | 620,000 | 13,503,600 | REDUCED | -41.9 | |
| VRNA | VERONA PHARMA PLC | 7.54 | 2,369,000 | 47,095,700 | UNCHANGED | 0.00 | |
| XLO | XILIO THERAPEUTICS INC | 0.16 | 1,785,000 | 981,750 | REDUCED | -23.01 | |
| STRUCTURE THERAPEUTICS INC | 2.70 | 414,000 | 16,874,600 | NEW | |||
| DIANTHUS THERAPEUTICS INC | 0.92 | 554,000 | 5,761,600 | ADDED | 15.42 |